Related Experiment Video
Updated: May 22, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
Subdural hemorrhage: A unique case involving secondary vitamin K deficiency bleeding due to biliary atresia
Masashi Miyao1, Hitoshi Abiru, Munetaka Ozeki
1Department of Forensic Medicine and Molecular Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Insights
Extrahepatic biliary atresia (EHBA) can cause vitamin K deficiency bleeding (VKDB) in infants, even with prophylaxis. This case highlights EHBA as a critical factor in unexplained infant subdural hemorrhage.
Area of Science:
- Pediatric Pathology
- Gastroenterology
- Neonatology
Background:
- Extrahepatic biliary atresia (EHBA) is a rare infant cholangiopathy causing fat malabsorption and vitamin K deficiency bleeding (VKDB).
- Breast milk's low vitamin K content can exacerbate bleeding risk in infants with EHBA.
- VKDB is a significant cause of intracranial hemorrhage in infants.
Observation:
- A 2-month-old infant with jaundice and vomiting died unexpectedly, with no history of trauma.
- CT scans revealed an intracranial hematoma with mass effect.
- Autopsy showed severe EHBA, cholestasis, and subdural hematoma without external injury.
Findings:
- The infant's subdural hemorrhage was attributed to secondary VKDB from EHBA-related cholestasis and breastfeeding.
- Even with oral vitamin K prophylaxis, secondary VKDB can lead to severe bleeding.
- Histological findings confirmed EHBA and associated cholestatic liver disease.
Implications:
- Intrinsic conditions like EHBA-induced VKDB should be considered in infant autopsies with subdural hemorrhage.
- This case underscores the importance of investigating underlying causes of VKDB beyond standard prophylaxis.
- Early diagnosis and management of EHBA are crucial to prevent life-threatening complications like intracranial bleeding.
Abstract:
Extrahepatic biliary atresia (EHBA) is a rare disease characterized by progressive and obliterative cholangiopathy in infants and is one of the major causes of secondary vitamin K deficiency bleeding (VKDB) due to cholestasis-induced fat malabsorption. Breast feeding increases the tendency of bleeding in EHBA patients because breast milk contains low amounts of vitamin K. A 2-month-old female infant unexpectedly died, with symptoms of vomiting and jaundice prior to death. She had been born by uncomplicated vaginal delivery and exhibited normal growth and development with breastfeeding. There was no history of trauma. She received vitamin K prophylaxis orally. In an emergency hospital, a CT scan showed a right intracranial hematoma and mass effect with midline shift to the left. In the postmortem examination, severe atresia was observed in the whole extrahepatic bile duct. Histologically, cholestasis, periductal fibrosis, and distorted bile ductules were noted. The gallbladder was not identified. A subdural hematoma and cerebellar tonsillar herniation were found; however, no traumatic injury in any part of the body was observed. Together, these findings suggest that the subdural hemorrhage was caused by secondary vitamin K deficiency resulting from a combination of cholestasis-induced fat malabsorption and breastfeeding. Subdural hemorrhage by secondary VKDB sometimes occurs even when vitamin K prophylaxis is continued. This case demonstrated that intrinsic factors, such as secondary VKDB (e.g., EHBA, neonatal hepatitis, chronic diarrhea), should also be considered in infant autopsy cases presenting with subdural hemorrhage.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke l: Introduction
Vitamins
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
